← Eichor
Study identifier: NCT07703618 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of Proximal Massage and Palm-to-Fist Tapping on Reducing the Risk of Phlebitis

Condition: Phlebitis · Catheter Complications  ·  Sponsor: Hospital Universitario San Ignacio

PhaseNA
Planned participants273
Who can joinAll sexes, 18 Years to 110 Years
Healthy volunteersNo

About this study

Phlebitis is a clinical condition that develops as a complication of peripheral venous catheter use. Peripheral venous catheterization is a common clinical procedure performed in hospitalized patients, as it provides vascular access for the administration of medications, blood products, and contrast media for diagnostic imaging studies. The pathophysiology of phlebitis involves inflammation of the vascular intima, leading to luminal narrowing and impaired blood flow. These changes are clinically manifested by local signs of inflammation, including erythema, edema, and pain, which have been objectively assessed using several validated clinical assessment scales.

This description comes directly from the study's public registry record.

Talk to the study team

Sandra Valderrama, Dra  ·  +57(601) 594616  ·  svalderrama.med@javeriana.edu.co

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Universitario San IgnacioBogotá, Bogota D.C., ColombiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07703618